OwlyTimes

#clinical-trials

4 articles with this tag

DBV Tech: Cash Runway Masks High Stakes for VIASKIN®Finance

DBV Tech: Cash Runway Masks High Stakes for VIASKIN®

Uncover the hidden risks behind DBV Tech's $288M cash runway. Our analysis reveals how VIASKIN®'s success dictates the company's future & allergy treatment...

HHS: Health Data as Utility—Analysis of the StakesHealth

HHS: Health Data as Utility—Analysis of the Stakes

Uncover the hidden implications of HHS's health data utility debate. Our analysis reveals who benefits & what it means for your privacy – don't miss it!

Rare Disease Trials: Tech's Impact & a New Clinical ShiftHealth

Rare Disease Trials: Tech's Impact & a New Clinical Shift

Uncover how tech is reshaping rare disease trials! Our analysis reveals a crucial clinical shift: patient-centric design & innovative strategies are key.

BioArctic's Cash: Analysis of a Critical Turning PointHealth

BioArctic's Cash: Analysis of a Critical Turning Point

Uncover BioArctic's pivotal moment! Our analysis reveals how $33M cash reserves shape their future amid rising costs & regulatory challenges. Gain key insights.